APTOF
Price
$1.18
Change
-$0.04 (-3.28%)
Updated
Sep 5 closing price
Capitalization
3.05M
WHWK
Price
$1.82
Change
+$0.01 (+0.55%)
Updated
Sep 5 closing price
Capitalization
85.77M
58 days until earnings call
Interact to see
Advertisement

APTOF vs WHWK

Header iconAPTOF vs WHWK Comparison
Open Charts APTOF vs WHWKBanner chart's image
Aptose Biosciences
Price$1.18
Change-$0.04 (-3.28%)
Volume$698
Capitalization3.05M
Whitehawk Therapeutics
Price$1.82
Change+$0.01 (+0.55%)
Volume$36.92K
Capitalization85.77M
APTOF vs WHWK Comparison Chart in %
Loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTOF vs. WHWK commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTOF is a Hold and WHWK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (APTOF: $1.18 vs. WHWK: $1.82)
Brand notoriety: APTOF and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTOF: 15% vs. WHWK: 35%
Market capitalization -- APTOF: $3.05M vs. WHWK: $85.77M
APTOF [@Biotechnology] is valued at $3.05M. WHWK’s [@Biotechnology] market capitalization is $85.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTOF’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • APTOF’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than APTOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTOF’s TA Score shows that 4 TA indicator(s) are bullish while WHWK’s TA Score has 5 bullish TA indicator(s).

  • APTOF’s TA Score: 4 bullish, 6 bearish.
  • WHWK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, WHWK is a better buy in the short-term than APTOF.

Price Growth

APTOF (@Biotechnology) experienced а -6.35% price change this week, while WHWK (@Biotechnology) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

WHWK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WHWK($85.8M) has a higher market cap than APTOF($3.05M). APTOF YTD gains are higher at: 423.746 vs. WHWK (-42.314). WHWK has higher annual earnings (EBITDA): -10.21M vs. APTOF (-20.11M). WHWK has more cash in the bank: 177M vs. APTOF (553K). WHWK has less debt than APTOF: WHWK (0) vs APTOF (11.4M). WHWK has higher revenues than APTOF: WHWK (21.6M) vs APTOF (0).
APTOFWHWKAPTOF / WHWK
Capitalization3.05M85.8M4%
EBITDA-20.11M-10.21M197%
Gain YTD423.746-42.314-1,001%
P/E RatioN/A11.67-
Revenue021.6M-
Total Cash553K177M0%
Total Debt11.4M0-
FUNDAMENTALS RATINGS
APTOF vs WHWK: Fundamental Ratings
APTOF
WHWK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
5361
P/E GROWTH RATING
1..100
10047
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for APTOF (87) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than APTOF’s over the last 12 months.

WHWK's Profit vs Risk Rating (98) in the Pharmaceuticals Major industry is in the same range as APTOF (100) in the Biotechnology industry. This means that WHWK’s stock grew similarly to APTOF’s over the last 12 months.

WHWK's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as APTOF (100) in the Biotechnology industry. This means that WHWK’s stock grew similarly to APTOF’s over the last 12 months.

APTOF's Price Growth Rating (53) in the Biotechnology industry is in the same range as WHWK (61) in the Pharmaceuticals Major industry. This means that APTOF’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's P/E Growth Rating (47) in the Pharmaceuticals Major industry is somewhat better than the same rating for APTOF (100) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than APTOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOFWHWK
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 25 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFBK24.740.44
+1.81%
CF Bankshares
AWK143.602.03
+1.43%
American Water Works Company
TMDX104.01-0.04
-0.04%
TransMedics Group
SANA2.96-0.02
-0.67%
Sana Biotechnology
BTBD2.30-0.57
-19.86%
BT Brands

APTOF and

Correlation & Price change

A.I.dvisor tells us that APTOF and WHWK have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and WHWK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
-3.48%
WHWK - APTOF
29%
Poorly correlated
+0.55%
XLO - APTOF
27%
Poorly correlated
-2.53%
LCTX - APTOF
26%
Poorly correlated
+1.67%
ORMP - APTOF
25%
Poorly correlated
+0.45%
CRIS - APTOF
24%
Poorly correlated
-1.75%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been closely correlated with ELVAF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if WHWK jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
+0.55%
ELVAF - WHWK
76%
Closely correlated
N/A
DMAC - WHWK
47%
Loosely correlated
+14.34%
TRAW - WHWK
39%
Loosely correlated
+7.51%
CLYYF - WHWK
37%
Loosely correlated
N/A
IDYA - WHWK
34%
Loosely correlated
+5.15%
More